Irregular Sleep Linked to Increased Risk for Major Adverse Cardiovascular Events
By Elana Gotkine HealthDay Reporter
FRIDAY, Dec. 6, 2024 -- Irregular sleep is associated with an increased risk for major adverse cardiovascular events (MACE), according to a study published online Nov. 26 in the Journal of Epidemiology & Community Health.
Jean-Philippe Chaput, Ph.D., from the Children's Hospital of Eastern Ontario Research Institute in Ottawa, Canada, and colleagues conducted a prospective cohort study of adults aged 40 to 79 years from the U.K. Biobank who wore wrist-attached accelerometers for seven days. For each participant, Sleep Regularity Index (SRI) scores were calculated and categorized as irregular, moderately irregular, or regular (SRI <71.6, 71.6 to 87.3, and >87.3, respectively).
Data were analyzed for 72,269 individuals followed for eight years without a previous history of MACE and with no event in the first year of follow-up. The researchers found that the risk for MACE was higher for irregular and moderately irregular sleepers versus regular sleepers (hazard ratios [95 percent confidence intervals], 1.26 [1.16 to 1.37] and 1.08 [1.01 to 1.70], respectively). Treating SRI as a continuous measure, dose-response analyses showed that SRI was associated with the risk for MACE in a near-linear manner, with a steeper risk reduction at higher SRI scores. Meeting the age-specific sleep duration recommendation offset MACE risk for moderately irregular sleepers (hazard ratio, 1.07; 95 percent confidence interval, 0.96 to 1.18), but not for irregular sleepers (hazard ratio, 1.19; 95 percent confidence interval, 1.06 to 1.35), in joint SRI and sleep duration analyses.
"Findings from this study suggest that more attention needs to be paid to sleep regularity in public health guidelines and clinical practice due to its potential role in cardiovascular health," the authors write. "Future studies are needed to explore whether interventions aimed at improving sleep regularity might improve cardiovascular health."
One author disclosed ties to the pharmaceutical and medical device industries.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-07 06:00
Read more
- Antiviral Treatment Underutilized for Children, Teens With Flu
- Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End
- Overtreatment Common for Older Men With Prostate Cancer
- Sixty Waterborne Disease Outbreaks Tied to Splash Pads From 1997 to 2022
- Twice-Yearly Injection 96% Effective in Preventing HIV Infection
- 2010 to 2022 Saw Drop in Hospital-Based Obstetric Care in U.S. Hospitals
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions